Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
ART0380 is being studied in a Phase 1/2 trial for various advanced or metastatic solid tumors and the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer [NA]
The trial investigating phenotypic characterization of tumor-infiltrating lymphocytes in ovarian cancer and fallopian tube cancer at diagnos…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Access to Genetic Testing in Underserved Patients With Cancer [NA]
This entry reports on a clinical trial investigating access to genetic testing for cancer patients in underserved populations, with recruitm…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intraperitoneal SK-NK cell injections for advanced ovarian cancer with massive ascites; recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Early Phase Study of KESONOTIDE™in Participants With Solid Tumours [Phase 1, Phase 2]
KESONOTIDE is being studied in an early-phase (Phase 1/Phase 2) trial for solid tumours and is currently recruiting across multiple cancer i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability study of XmAb541 in advanced solid tumors is currently recruiting, investigating ovarian cancer, endometrial…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]
ATV-1601, an investigational therapy, is being studied in a Phase 1 trial for patients with AKT1 E17K-mutant cancers, including breast, cerv…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial is evaluating maintenance therapy with BGB-290 (pamiparib) versus placebo in platinum-sensitive recurrent ovarian cancer, an…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating MUC1-Activated T Cells for relapsed and resistant ovarian, fallopian tube, and primary peritoneal cancers;…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) [Phase 3]
Phase 3 CHIPPI trial evaluating hyperthermic intraperitoneal chemotherapy for ovarian cancer; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with bevacizumab, with or without the anti-CD40 agonist CDX-1140, for recur…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients [Phase 2]
A Phase 2 clinical trial update describes a combination therapy strategy to prevent resistance to anti-PD-1 therapy in metastatic ovarian ca…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluates a PARP inhibitor with or without an angiogenesis inhibitor in patients with homologous recombinat…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected [Phase 3]
A Phase 3 trial of alpelisib plus olaparib for platinum-resistant/refractory high-grade serous ovarian cancer without germline BRCA mutation…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: CYTALUX Dose Extension Study [Phase 4]
Phase 4 dose-extension study of CYTALUX by On Target Laboratories; the trial is not yet recruiting and targets lung cancer and ovarian cance…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy [NA]
Clinical trial update on perioperative morbidity in gyneco-oncology comparing coelioscopy to robot-assisted coelioscopy. The Centre Oscar La…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
This clinical trial investigates how biological, genetic, and constitutional factors, plus non-invasive monitoring, can help assess individu…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]
PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating NKT5097 in adults with advanced or metastatic solid tumors, including various breast cancer subtypes and gynecologi…
-
CLINICAL_TRIALS other · 2026-03-12Clinical Trial Update: Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery [Phase 2]
A Phase 2 clinical trial evaluating multimodal prehabilitation alone or with neoadjuvant therapy before major cancer surgery is currently re…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]
This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, inclu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro [Phase 2]
Phase 2 clinical trial in newly diagnosed stage III/IV ovarian cancer evaluating neoadjuvant carboplatin/paclitaxel/pembrolizumab followed b…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer - Phase III
Phase III international study to evaluate the reliability and validity of the QLQ-OV28 ovarian cancer quality-of-life questionnaire; current…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery [Phase 2]
Phase 2 clinical trial evaluating Radspherin in patients with primary advanced epithelial cancer and peritoneal metastasis who are homologou…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This document describes a Phase 1 trial evaluating the combination of niraparib and copanlisib in patients with recurrent endometrial, ovari…